Regulation of GIP and GLP1 receptor cell surface expression by N-glycosylation and receptor heteromerization.
In response to a meal, Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) are released from gut endocrine cells into the circulation and interact with their cognate G-protein coupled receptors (GPCRs). Receptor activation results in tissue-selective pleiotropic re...
Hauptverfasser: | Gina M Whitaker, Francis C Lynn, Christopher H S McIntosh, Eric A Accili |
---|---|
Format: | Artikel |
Sprache: | English |
Veröffentlicht: |
Public Library of Science (PLoS)
2012-01-01
|
Schriftenreihe: | PLoS ONE |
Online Zugang: | http://europepmc.org/articles/PMC3296735?pdf=render |
Ähnliche Einträge
Ähnliche Einträge
-
Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide
von: Karen Schneck, et al.
Veröffentlicht: (2024-03-01) -
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
von: Francis S. Willard, et al.
Veröffentlicht: (2020-09-01) -
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
von: Qiyuan Keith Liu
Veröffentlicht: (2024-07-01) -
Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?
von: Miodrag Janić, et al.
Veröffentlicht: (2024-12-01) -
Bumps and humps in the success of Tirzepatide as the first GLP1 and GIP receptor agonist
von: Rouchan Ali, et al.
Veröffentlicht: (2022-09-01)